and no signal for supine hypertension. In the US, the Company has been granted an Orphan Drug Designation for ampreloxetine for the treatment of symptomatic nOH in patients with MSA and, if results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback